LNTH: Lantheus Holdings, Inc. Stock

by  •  • Comments Off on LNTH: Lantheus Holdings, Inc. Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 5,453.30
Enterprise Value ($M) 5,080.86
Book Value ($M) 1,164.19
Book Value / Share 16.83
Price / Book 4.68
NCAV ($M) 532.75
NCAV / Share 7.70
Price / NCAV 10.24

Profitability (mra)
Return on Invested Capital (ROIC) 0.14
Return on Assets (ROA) 0.14
Return on Equity (ROE) 0.27

Liquidity (mrq)
Quick Ratio 5.46
Current Ratio 5.74

Balance Sheet (mrq) ($M)
Current Assets 1,423.78
Assets 2,055.22
Liabilities 891.03
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,533.91
Operating Income 448.56
Net Income 312.44
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 544.75
Cash from Investing -226.01
Cash from Financing -118.54

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
1 day ago 13G/A Janus Henderson Group Plc 9.50 5.11

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2025-02-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-07-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-14 521,821 1,659,790 31.44
2025-05-13 263,805 982,757 26.84
2025-05-12 615,060 1,949,644 31.55
2025-05-09 541,642 1,399,702 38.70

(click for more detail)

Similar Companies
KROS – Keros Therapeutics, Inc. KYMR – Kymera Therapeutics, Inc.
LGND – Ligand Pharmaceuticals Incorporated LRMR – Larimar Therapeutics, Inc.
LXEO – Lexeo Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io